Defective Autophagy and mTORC1 Signaling in Myotubularin Null Mice
Open accessThe DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
Abstract
Autophagy is a vesicular trafficking pathway that regulates the degradation of aggregated proteins and damaged organelles. Initiation of autophagy requires several multiprotein signaling complexes, such as the ULK1 kinase complex and the Vps34 lipid kinase complex, which generates phosphatidylinositol 3-phosphate [PtdIns(3)P] on the forming autophagosomal membrane. Alterations in autophagy have been reported for various diseases, including myopathies. Here we show that skeletal muscle autophagy is compromised in mice deficient in the X-linked myotubular myopathy (XLMTM)-associated PtdIns(3)P phosphatase myotubularin (MTM1). Mtm1-deficient muscle displays several cellular abnormalities, including a profound increase in ubiquitin aggregates and abnormal mitochondria. Further, we show that Mtm1 deficiency is accompanied by activation of mTORC1 signaling, which persists even following starvation. In vivo pharmacological inhibition of mTOR is sufficient to normalize aberrant autophagy and improve muscle phenotypes in Mtm1 null mice. These results suggest that aberrant mTORC1 signaling and impaired autophagy are consequences of the loss of Mtm1 and may play a primary role in disease pathogenesis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“(ii) X‐linked myotubular myopathies, as defective autophagy is detected in Mtm1 (X‐linked myotubular myopathy gene 1)‐deficient mouse muscle (Fetalvero et al, 2013)”
From Autophagy in major human diseases (2021) · cites this paper as Fetalvero et al, 2013
In the citing paper
“Myopathic defects associated with impaired autophagic flux and abnormal mitochondria”
From Autophagy in major human diseases (2021) · cites this paper as Fetalvero et al (2013)
Citations
Cites
AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1
Kim, J., Kundu, M., Viollet, B., & Guan, K.-L. (2011) · Nature Cell Biology · doi:10.1038/ncb2152 · Cited by 7,227 · cited 1×
“One way in which mTOR is believed to inhibit autophagy is direct phosphorylation of ULK1 (12–14), and a recent study identified ULK1 as an mTOR-regulated phosphorylation site (45).”
BackgroundAutophagy in the Pathogenesis of Disease
Levine, B., & Kroemer, G. (2008) · Cell · doi:10.1016/j.cell.2007.12.018 · Cited by 7,069 · cited 4×
“Nutrient limitation represents one of the major ways in which autophagy is activated, and in this context, the recycling of cellular components provides the cell with a source of ATP and amino acids to maintain normal homeostatic processes (1).”
BackgroundInfluentialTOR signaling in growth and metabolism
Wullschleger, S., Loewith, R., & Hall, M. N. (2006) · Cell · doi:10.1016/j.cell.2006.01.016 · Cited by 5,787 · cited 9×
“This complex is regulated by mTOR (12–14), which itself assembles into two multiprotein complexes termed mTORC1 and mTORC2 (15).”
BackgroundInfluentialPankiv, S., Clausen, T. H., Lamark, T., Brech, A., Bruun, J.-A., Outzen, H., Øvervatn, A., Bjørkøy, G., & Johansen, T. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m702824200 · Cited by 4,578 · cited 2×
“These observations are consistent with previous reports showing that elevated levels of p62, a key molecule involved in the targeting of ubiquitinated proteins to the autophagosome, contribute to the aggregation of ubiquitinated proteins when autophagic flux is reduced (4, 41).”
BackgroundResultSuppression of basal autophagy in neural cells causes neurodegenerative disease in mice
Hara, T., Nakamura, K., Matsui, M., Yamamoto, A., Nakahara, Y., Suzuki-Migishima, R., Yokoyama, M., Mishima, K., Saito, I., Okano, H., et al. (2006) · Nature · doi:10.1038/nature04724 · Cited by 3,882
Loss of autophagy in the central nervous system causes neurodegeneration in mice
Komatsu, M., Waguri, S., Chiba, T., Murata, S., Iwata, J.-I., Tanida, I., Ueno, T., Koike, M., Uchiyama, Y., Kominami, E., et al. (2006) · Nature · doi:10.1038/nature04723 · Cited by 3,500 · cited 8×
“MTM1 and related phosphatases can dephosphorylate PtdIns(3)P in vitro (25) and may therefore oppose the action of Vps34.”
BackgroundMethodInfluentialTFEB Links Autophagy to Lysosomal Biogenesis
Settembre, C., Di Malta, C., Polito, V. A., Arencibia, M. G., Vetrini, F., Erdin, S., Erdin, S. U., Huynh, T., Medina, D., Colella, P., et al. (2011) · Science · doi:10.1126/science.1204592 · Cited by 3,365
Wallace, D. C. (2005) · Annual Review of Genetics · doi:10.1146/annurev.genet.39.110304.095751 · Cited by 3,185 · cited 1×
“damage (50), and changes in mitochondrial content and function”
BackgroundKim, D.-H., Sarbassov, D. D., Ali, S. M., King, J. E., Latek, R. R., Erdjument-Bromage, H., Tempst, P., & Sabatini, D. M. (2002) · Cell · doi:10.1016/s0092-8674(02)00808-5 · Cited by 2,986
The Rag GTPases Bind Raptor and Mediate Amino Acid Signaling to mTORC1
Sancak, Y., Peterson, T. R., Shaul, Y. D., Lindquist, R. A., Thoreen, C. C., Bar-Peled, L., & Sabatini, D. M. (2008) · Science · doi:10.1126/science.1157535 · Cited by 2,773 · cited 2×
“Recent reports suggest that activation of mTOR in response to amino acids requires redistribution of mTOR to lysosomes (56), where it encounters its upstream activator Rheb (56, 57).”
BackgroundSarbassov, D. D., Ali, S. M., Kim, D.-H., Guertin, D. A., Latek, R. R., Erdjument-Bromage, H., Tempst, P., & Sabatini, D. M. (2004) · Current Biology · doi:10.1016/j.cub.2004.06.054 · Cited by 2,665
Sancak, Y., Bar-Peled, L., Zoncu, R., Markhard, A. L., Nada, S., & Sabatini, D. M. (2010) · Cell · doi:10.1016/j.cell.2010.02.024 · Cited by 2,464 · cited 3×
“Recent reports suggest that activation of mTOR in response to amino acids requires redistribution of mTOR to lysosomes (56), where it encounters its upstream activator Rheb (56, 57).”
BackgroundKomatsu, M., Kurokawa, H., Waguri, S., Taguchi, K., Kobayashi, A., Ichimura, Y., Sou, Y.-S., Ueno, I., Sakamoto, A., Tong, K. I., et al. (2010) · Nature Cell Biology · doi:10.1038/ncb2021 · Cited by 2,288 · cited 1×
“This observation is consistent with recent reports showing that reduced autophagic turnover of p62 leads to deleterious activation of Nrf2 (nuclear factor erythroid 2-related factor 2), the transcription factor that regulates the expression of enzymes induced in response to oxidative stress (42).”
ResultHomeostatic levels of p62 control cytoplasmic inclusion body formation in autophagy-deficient mice.
Komatsu, M., Waguri, S., Koike, M., Sou, Y.-S., Ueno, T., Hara, T., Mizushima, N., Iwata, J.-I., Ezaki, J., Murata, S., et al. (2007) · Cell · doi:10.1016/j.cell.2007.10.035 · Cited by 2,124 · cited 17×
“MTM1 and related phosphatases can dephosphorylate PtdIns(3)P in vitro (25) and may therefore oppose the action of Vps34.”
BackgroundResultInfluentialMizushima, N., Yamamoto, A., Matsui, M., Yoshimori, T., & Ohsumi, Y. (2004) · Molecular Biology of the Cell · doi:10.1091/mbc.e03-09-0704 · Cited by 2,105 · cited 2×
“To determine if Mtm1 is required for starvation-induced autophagy in vivo, mice were fasted for 20 h as previously described (43).”
BackgroundMethodNutrient-dependent mTORC1 Association with the ULK1–Atg13–FIP200 Complex Required for Autophagy
Hosokawa, N., Hara, T., Kaizuka, T., Kishi, C., Takamura, A., Miura, Y., Iemura, S.-I., Natsume, T., Takehana, K., Yamada, N., et al. (2009) · Molecular Biology of the Cell · doi:10.1091/mbc.e08-12-1248 · Cited by 2,076
ULK-Atg13-FIP200 Complexes Mediate mTOR Signaling to the Autophagy Machinery
Jung, C. H., Jun, C. B., Ro, S.-H., Kim, Y.-M., Otto, N. M., Cao, J., Kundu, M., & Kim, D.-H. (2009) · Molecular Biology of the Cell · doi:10.1091/mbc.e08-12-1249 · Cited by 2,025
Axe, E. L., Walker, S. A., Manifava, M., Chandra, P., Roderick, H. L., Habermann, A., Griffiths, G., & Ktistakis, N. T. (2008) · The Journal of Cell Biology · doi:10.1083/jcb.200803137 · Cited by 1,885 · cited 1×
“The exact role of PtdIns(3)P in autophagy is unclear, but studies suggest that PtdIns(3)P recruits specific effector proteins such as Atg18/WIPI (22, 23) and DFCP1 (double FYVE domaincontaining protein 1) (19), both of which may play a role in autophagosome formation.”
BackgroundRaptor, a Binding Partner of Target of Rapamycin (TOR), Mediates TOR Action
Hara, K., Maruki, Y., Long, X., Yoshino, K.-I., Oshiro, N., Hidayat, S., Tokunaga, C., Avruch, J., & Yonezawa, K. (2002) · Cell · doi:10.1016/s0092-8674(02)00833-4 · Cited by 1,810
Thoreen, C. C., Kang, S. A., Chang, J. W., Liu, Q., Zhang, J., Gao, Y., Reichling, L. J., Sim, T., Sabatini, D. M., & Gray, N. S. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m900301200 · Cited by 1,803 · cited 1×
“mTORC1 outputs such as 4EBP1 and autophagy, which are only modestly affected by rapamycin (47, 48).”
BackgroundRegulation of Mammalian Autophagy in Physiology and Pathophysiology
Ravikumar, B., Sarkar, S., Davies, J. E., Futter, M., Garcia-Arencibia, M., Green-Thompson, Z. W., Jimenez-Sanchez, M., Korolchuk, V. I., Lichtenberg, M., Luo, S., et al. (2010) · Physiological Reviews · doi:10.1152/physrev.00030.2009 · Cited by 1,727 · cited 2×
“Inhibition of mTORC1 by nutrient deprivation or pharmacological inhibitors such as rapamycin results in the activation of ULK1 and autophagy (11).”
BackgroundAutophagy in mammalian development and differentiation
Mizushima, N., & Levine, B. (2010) · Nature Cell Biology · doi:10.1038/ncb0910-823 · Cited by 1,555 · cited 2×
“Autophagy has a critical role in maintaining cellular quality control of proteins and organelles, and accumulation of ubiquitin, p62, and Nbr1 protein aggregates is observed in tissue-specific Atg gene knockout mouse models, as is the accumulation of deformed or dysfunctional mitochondria (44).”
BackgroundThe role of autophagy in cardiomyocytes in the basal state and in response to hemodynamic stress
Nakai, A., Yamaguchi, O., Takeda, T., Higuchi, Y., Hikoso, S., Taniike, M., Omiya, S., Mizote, I., Matsumura, Y., Asahi, M., et al. (2007) · Nature Medicine · doi:10.1038/nm1574 · Cited by 1,520 · cited 15×
“MTM1 and related phosphatases can dephosphorylate PtdIns(3)P in vitro (25) and may therefore oppose the action of Vps34.”
BackgroundInfluentialULK1·ATG13·FIP200 Complex Mediates mTOR Signaling and Is Essential for Autophagy
Ganley, I. G., Lam, D. H., Wang, J., Ding, X., Chen, S., & Jiang, X. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m900573200 · Cited by 1,447
MTORC1 functions as a transcriptional regulator of autophagy by preventing nuclear transport of TFEB
Martina, J. A., Chen, Y., Gucek, M., & Puertollano, R. (2012) · Autophagy · doi:10.4161/auto.19653 · Cited by 1,333 · cited 1×
“Second, mTORC1-regulated inhibition of transcription factor EB (54, 55), a master regulator of lysosome biogenesis, would lead to decreased synthesis of lysosomal hydrolases and a reduced number of lysosomes, resulting in a failure to degrade autophagic cargo and any existing LC3-II.”
BackgroundAutophagy is required to maintain muscle mass.
Masiero, E., Agatea, L., Mammucari, C., Blaauw, B., Loro, E., Komatsu, M., Metzger, D., Reggiani, C., Schiaffino, S., & Sandri, M. (2009) · Cell Metabolism · doi:10.1016/j.cmet.2009.10.008 · Cited by 1,282 · cited 2×
“Musclespecific deletion of Atg5 or Atg7 results in muscle atrophy and a decrease in muscle strength (8, 9).”
BackgroundChen, H., Vermulst, M., Wang, Y. E., Chomyn, A., Prolla, T. A., McCaffery, J. M., & Chan, D. C. (2010) · Cell · doi:10.1016/j.cell.2010.02.026 · Cited by 1,211 · cited 1×
“are critical to the maintenance of muscle function (51, 52).”
BackgroundA Role for NBR1 in Autophagosomal Degradation of Ubiquitinated Substrates
Kirkin, V., Lamark, T., Sou, Y.-S., Bjørkøy, G., Nunn, J. L., Bruun, J.-A., Shvets, E., McEwan, D. G., Clausen, T. H., Wild, P., et al. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.01.020 · Cited by 1,065 · cited 1×
“p62 and Nbr1 are LC3-interacting proteins that are degraded via autophagy (4, 40, 41), and their expression was elevated in Mtm1 muscle (Fig.”
BackgroundRapamycin passes the torch: a new generation of mTOR inhibitors
Benjamin, D., Colombi, M., Moroni, C., & Hall, M. N. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3531 · Cited by 989 · cited 2×
“Several small-molecule inhibitors that act as ATP-competitive inhibitors have been recently developed (46).”
BackgroundBlommaart, E. F. C., Krause, U., Schellens, J. P. M., Vreeling‐Sindelárová, H., & Meijer, A. J. (1997) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1997.0240a.x · Cited by 869 · cited 1×
“Autophagy inactivation by PtdIns(3)P phosphatases is poorly understood but is likely because wortmannin, which inhibits Vps34, also inhibits autophagy (24).”
BackgroundItakura, E., & Mizushima, N. (2010) · Autophagy · doi:10.4161/auto.6.6.12709 · Cited by 843
Chresta, C. M., Davies, B. R., Hickson, I., Harding, T., Cosulich, S., Critchlow, S. E., Vincent, J. P., Ellston, R., Jones, D., Sini, P., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-1751 · Cited by 812 · cited 1×
“To determine the potential of these compounds to activate autophagy in muscle, we treated mice with the allosteric inhibitor RAD001 or the ATPcompetitive inhibitor AZD8055 (49).”
Ebato, C., Uchida, T., Arakawa, M., Komatsu, M., Ueno, T., Komiya, K., Azuma, K., Hirose, T., Tanaka, K., Kominami, E., et al. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.08.009 · Cited by 774
Loss of Autophagy Diminishes Pancreatic β Cell Mass and Function with Resultant Hyperglycemia
Jung, H. S., Chung, K. W., Won Kim, J., Kim, J., Komatsu, M., Tanaka, K., Nguyen, Y. H., Kang, T. M., Yoon, K.-H., Kim, J.-W., et al. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.08.013 · Cited by 647
Mitochondrial fission and remodelling contributes to muscle atrophy
Romanello, V., Guadagnin, E., Gomes, L., Roder, I., Sandri, C., Petersen, Y., Milan, G., Masiero, E., Del Piccolo, P., Foretz, M., et al. (2010) · The EMBO Journal · doi:10.1038/emboj.2010.60 · Cited by 596 · cited 1×
“are critical to the maintenance of muscle function (51, 52).”
BackgroundGrumati, P., Coletto, L., Sabatelli, P., Cescon, M., Angelin, A., Bertaggia, E., Blaauw, B., Urciuolo, A., Tiepolo, T., Merlini, L., et al. (2010) · Nature Medicine · doi:10.1038/nm.2247 · Cited by 540 · cited 1×
“Autophagy inhibition is thought to play a role in many myopathies with inclusions or abnormal mitochondria (1, 60, 61), and the present observations indicate that correction of defects in autophagy may improve muscle defects associated with XLMTM.”
BackgroundCoordination of membrane events during autophagy by multiple class III PI3-kinase complexes
Simonsen, A., & Tooze, S. A. (2009) · Journal of Cell Biology · doi:10.1083/jcb.200907014 · Cited by 497 · cited 2×
“The levels of PtdIns(3)P were significantly elevated in Mtm1 null muscle, and on the basis of current models (10, 32), this should overactivate autophagy.”
BackgroundAutophagy requires endoplasmic reticulum targeting of the PI3-kinase complex via Atg14L
Matsunaga, K., Morita, E., Saitoh, T., Akira, S., Ktistakis, N. T., Izumi, T., Noda, T., & Yoshimori, T. (2010) · Journal of Cell Biology · doi:10.1083/jcb.200911141 · Cited by 456
PAULIN, D., & LI, Z. (2004) · Experimental Cell Research · doi:10.1016/j.yexcr.2004.08.004 · Cited by 451 · cited 1×
“has an essential role in muscle architecture maintenance (39).”
BackgroundRaben, N., Hill, V., Shea, L., Takikita, S., Baum, R., Mizushima, N., Ralston, E., & Plotz, P. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn292 · Cited by 352 · cited 2×
“Musclespecific deletion of Atg5 or Atg7 results in muscle atrophy and a decrease in muscle strength (8, 9).”
BackgroundObara, K., Sekito, T., Niimi, K., & Ohsumi, Y. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m803180200 · Cited by 350 · cited 2×
“In fact, this was not observed, which is surprising because one might expect that an increase in PtdIns(3)P would promote excessive autophagy by increasing the recruitment of Vps34 effector proteins Atg18/WIPI and DFCP1 to autophagosome formation sites.”
BackgroundRamos, F. J., Chen, S. C., Garelick, M. G., Dai, D.-F., Liao, C.-Y., Schreiber, K. H., MacKay, V. L., An, E. H., Strong, R., Ladiges, W. C., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003802 · Cited by 349 · cited 1×
“Autophagy inhibition is thought to play a role in many myopathies with inclusions or abnormal mitochondria (1, 60, 61), and the present observations indicate that correction of defects in autophagy may improve muscle defects associated with XLMTM.”
BackgroundTaylor, G. S., Maehama, T., & Dixon, J. E. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.160255697 · Cited by 338
Proikas-Cezanne, T., Waddell, S., Gaugel, A., Frickey, T., Lupas, A., & Nordheim, A. (2004) · Oncogene · doi:10.1038/sj.onc.1208331 · Cited by 332 · cited 2×
“In fact, this was not observed, which is surprising because one might expect that an increase in PtdIns(3)P would promote excessive autophagy by increasing the recruitment of Vps34 effector proteins Atg18/WIPI and DFCP1 to autophagosome formation sites.”
BackgroundCentronuclear (myotubular) myopathy
Jungbluth, H., Wallgren-Pettersson, C., & Laporte, J. (2008) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-3-26 · Cited by 321
Control of autophagy initiation by phosphoinositide 3‐phosphatase jumpy
Vergne, I., Roberts, E., Elmaoued, R. A., Tosch, V., Delgado, M. A., Proikas‐Cezanne, T., Laporte, J., & Deretic, V. (2009) · The EMBO Journal · doi:10.1038/emboj.2009.159 · Cited by 270 · cited 1×
“The levels of PtdIns(3)P were significantly elevated in Mtm1 null muscle, and on the basis of current models (10, 32), this should overactivate autophagy.”
BackgroundMyotubularin phosphatases: policing 3-phosphoinositides
Robinson, F. L., & Dixon, J. E. (2006) · Trends in Cell Biology · doi:10.1016/j.tcb.2006.06.001 · Cited by 242 · cited 2×
“MTM1 and related phosphatases can dephosphorylate PtdIns(3)P in vitro (25) and may therefore oppose the action of Vps34.”
BackgroundMTM1 mutations in X-linked myotubular myopathy
Laporte, J., Biancalana, V., Tanner, S. M., Kress, W., Schneider, V., Wallgren-Pettersson, C., Herger, F., Buj-Bello, A., Blondeau, F., Liechti-Gallati, S., et al. (2000) · Human Mutation · doi:10.1002/(sici)1098-1004(200005)15:5<393::aid-humu1>3.0.co;2-r · Cited by 234 · cited 1×
“The most severe cases of XLMTM are associated with mutations that abolish MTM1 phosphatase activity (29, 30).”
BackgroundBuj-Bello, A., Laugel, V., Messaddeq, N., Zahreddine, H., Laporte, J., Pellissier, J.-F., & Mandel, J.-L. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.212498399 · Cited by 230 · cited 2×
“reports showing that skeletal muscle is the primary tissue affected in this disease (37).”
BackgroundResultPhosphoinositide 3-kinase in disease: timing, location, and scaffolding
Wymann, M. P., & Marone, R. (2005) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2005.02.011 · Cited by 209 · cited 1×
“Since MTM1 can dephosphorylate PtdIns(3)P (25), one might expect that MTM1 deficiency would lead to overactivation of autophagy, similar to the AKT pathway gain of function in cells lacking phosphatase and tensin homolog, a PtdIns(3,4,5)P3 phosphatase (31).”
BackgroundModulation of Local PtdIns3P Levels by the PI Phosphatase MTMR3 Regulates Constitutive Autophagy
Taguchi-Atarashi, N., Hamasaki, M., Matsunaga, K., Omori, H., Ktistakis, N. T., Yoshimori, T., & Noda, T. (2010) · Traffic · doi:10.1111/j.1600-0854.2010.01034.x · Cited by 199
Chronic Activation of mTOR Complex 1 Is Sufficient to Cause Hepatocellular Carcinoma in Mice
Menon, S., Yecies, J. L., Zhang, H. H., Howell, J. J., Nicholatos, J., Harputlugil, E., Bronson, R. T., Kwiatkowski, D. J., & Manning, B. D. (2012) · Science Signaling · doi:10.1126/scisignal.2002739 · Cited by 182 · cited 1×
“Importantly, similar increases in both LC3-I and -II were also reported in mice with liver-specific knockout of TSC1 (tuberous sclerosis complex 1) (53), an upstream inhibitor of mTORC1 activation.”
BackgroundCao, C., Backer, J. M., Laporte, J., Bedrick, E. J., & Wandinger-Ness, A. (2008) · Molecular Biology of the Cell · doi:10.1091/mbc.e08-04-0367 · Cited by 147 · cited 1×
“Since MTM1 regulates endosomal membrane trafficking (58, 59), further work is needed to determine whether MTM1 negatively impacts the ability of nutrients to drive mTOR distribution toward lysosomes.”
BackgroundHnia, K., Tronchère, H., Tomczak, K. K., Amoasii, L., Schultz, P., Beggs, A. H., Payrastre, B., Mandel, J. L., & Laporte, J. (2011) · Journal of Clinical Investigation · doi:10.1172/jci44021 · Cited by 146 · cited 2×
“Loss of Mtm1 leads to mislocalization and aggregation of the IF protein desmin (38), which is the major muscle-specific IF protein.”
BackgroundResultBuj-Bello, A., Fougerousse, F., Schwab, Y., Messaddeq, N., Spehner, D., Pierson, C. R., Durand, M., Kretz, C., Danos, O., Douar, A.-M., et al. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn112 · Cited by 132
Wallgren-Pettersson, C., Clarke, A., Samson, F., Fardeau, M., Dubowitz, V, Moser, H., Grimm, T., Barohn, R. J., & Barth, P. G. (1995) · Journal of Medical Genetics · doi:10.1136/jmg.32.9.673 · Cited by 131 · cited 1×
“Muscle biopsy specimens from patients have revealed the presence of small, rounded myofibers and central nuclei (27, 28).”
BackgroundDrosophila Mtm and class II PI3K coregulate a PI(3)P pool with cortical and endolysosomal functions
Velichkova, M., Juan, J., Kadandale, P., Jean, S., Ribeiro, I., Raman, V., Stefan, C., & Kiger, A. A. (2010) · Journal of Cell Biology · doi:10.1083/jcb.200911020 · Cited by 95 · cited 1×
“Since MTM1 regulates endosomal membrane trafficking (58, 59), further work is needed to determine whether MTM1 negatively impacts the ability of nutrients to drive mTOR distribution toward lysosomes.”
BackgroundRelieving Autophagy and 4EBP1 from Rapamycin Resistance
Nyfeler, B., Bergman, P., Triantafellow, E., Wilson, C. J., Zhu, Y., Radetich, B., Finan, P. M., Klionsky, D. J., & Murphy, L. O. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.05430-11 · Cited by 94 · cited 2×
“mTORC1 outputs such as 4EBP1 and autophagy, which are only modestly affected by rapamycin (47, 48).”
BackgroundMethodSelf-citationDowling, J. J., Low, S. E., Busta, A. S., & Feldman, E. L. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq153 · Cited by 87
Myofiber size correlates with MTM1 mutation type and outcome in X-linked myotubular myopathy
Pierson, C. R., Agrawal, P. B., Blasko, J., & Beggs, A. H. (2007) · Neuromuscular Disorders · doi:10.1016/j.nmd.2007.03.010 · Cited by 49 · cited 1×
“Muscle biopsy specimens from patients have revealed the presence of small, rounded myofibers and central nuclei (27, 28).”
BackgroundLight microscopic methods to visualize mitochondria on tissue sections
Tanji, K., & Bonilla, E. (2008) · Methods · doi:10.1016/j.ymeth.2008.09.027 · Cited by 37 · cited 1×
“0 m for subsequent cytochrome c oxidase (COX) and succinate dehydrogenase (SDH) enzyme activity staining by standard histochemical staining methods (36).”
Method
Cited by
Autophagy in major human diseases
Klionsky, D. J., Petroni, G., Amaravadi, R. K., Baehrecke, E. H., Ballabio, A., Boya, P., Bravo‐San Pedro, J. M., Cadwell, K., Cecconi, F., Choi, A. M. K., et al. (2021) · The EMBO Journal · doi:10.15252/embj.2021108863 · Cited by 1,585
Phosphatidylinositol 3-phosphates—at the interface between cell signalling and membrane traffic
Marat, A. L., & Haucke, V. (2016) · The EMBO Journal · doi:10.15252/embj.201593564 · Cited by 299
“As an example, MTM1-deficient muscles from knock-out mice display elevated mTORC1 activity that persists after starvation resulting in a defect in autophagy (Fetalvero et al , 2013).”
Congenital myopathies: disorders of excitation–contraction coupling and muscle contraction
Jungbluth, H., Treves, S., Zorzato, F., Sarkozy, A., Ochala, J., Sewry, C., Phadke, R., Gautel, M., & Muntoni, F. (2018) · Nature Reviews Neurology · doi:10.1038/nrneurol.2017.191 · Cited by 280
The intricate regulation and complex functions of the Class III phosphoinositide 3-kinase Vps34
Backer, J. M. (2016) · Biochemical Journal · doi:10.1042/bcj20160170 · Cited by 238
Regulation of autophagy by amino acids and MTOR-dependent signal transduction
Meijer, A. J., Lorin, S., Blommaart, E. F., & Codogno, P. (2015) · Amino Acids · doi:10.1007/s00726-014-1765-4 · Cited by 190
“The observation that in skeletal muscle of mice deficient of myotubularin, the lipid phosphatase responsible for the degradation of PI(3)P, autophagy is defective and MTOR overactivated (Fetalvero et al. 2013) may be explained similarly.”
Background
Metadata
- Authors
- Fetalvero, K. M., Yu, Y., Goetschkes, M., Liang, G., Valdez, R. A., Gould, T., Triantafellow, E., Bergling, S., Loureiro, J., Eash, J., Lin, V., Porter, J. A., Finan, P. M., Walsh, K., Yang, Y., Mao, X., & Murphy, L. O.
- Affiliations
- Developmental and Molecular Pathways, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts, USA
- Metabolism and Pharmacokinetics, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts, USA
- Novartis Institutes for BioMedical Research (CH)
- Boston University (US)
- Venue
- Molecular and Cellular Biology
- Publisher
- Informa UK Limited
- Published
- 2013-01-01
- Volume
- 33
- Issue
- 1
- Pages
- 98-110
- ISSN
- 0270-7306 (ISSN-L)
- 1098-5549
- PMC
- PMC3536306
- OpenAlex
- W2108486519
- Cited by
- 96
- References
- 61
- Citations by year
- 2026: 3 · 2025: 7 · 2024: 7 · 2023: 2 · 2022: 9 · 2021: 9 · 2020: 7 · 2019: 6 · 2018: 8 · 2017: 2 · 2016: 14 · 2015: 6 · 2014: 9 · 2013: 7
- FWCI
- 5.25
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- Molecular and Cellular Biology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute on Aging (R01AG034972)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Glycogen Storage Diseases and Myoclonus
- Keywords
- autophagy, mTORC1 signaling, myotubularin, MTM1, X-linked myotubular myopathy, skeletal muscle, mitochondrial abnormalities, starvation, mTOR inhibition, autophagosomal membrane
- MeSH terms
- Mechanistic Target of Rapamycin Complex 1, Animals, Autophagy, Mice, Inbred C57BL, Mice, Mutant Strains, Mitochondria, Proteins, Signal Transduction, Phosphatidylinositol Phosphates, Muscle, Skeletal, Sirolimus, Myopathies, Structural, Congenital, Ubiquitin, Multiprotein Complexes, Mice, Protein Tyrosine Phosphatases, Non-Receptor, TOR Serine-Threonine Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.